Dow Up 0.08% Nasdaq Down 0.30%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.27 0.08(6.72%) Sep 19, 4:00PM EDT
Prev Close:1.19
Open:1.17
Bid:1.01 x 300
Ask:1.35 x 3000
1y Target Est:1.67
Beta:0.71
Next Earnings Date:N/A
Day's Range:1.12 - 1.30
52wk Range:1.00 - 2.35
Volume:972,520
Avg Vol (3m):783,123
Market Cap:65.74M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AVEOUp 6.72%65.74M
AMGN109.39B
PFE192.76B
RHHBY255.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback